论文部分内容阅读
目的:采用胺碘酮治疗心力衰竭并心房颤动症状,观察临床疗效。方法:选择我院收治的27例患者的临床治疗资料,尊重患者治疗意愿将其分为治疗组15例,对照组12例,对照组采用常规治疗,使用地戈辛、ACEI、利尿药。治疗组在对照组基础上增加静脉注射胺碘酮溶液及口服胺碘酮,观察两组患者的临床疗效。结果:治疗组患者心功能改善情况、转复作用明显高于对照组,有显著性差异(P<0.05)。结论:胺碘酮在治疗心力衰竭并心房颤动症状上有明显改善,值得临床推广使用。
Objective: Amiodarone treatment of heart failure and atrial fibrillation symptoms, clinical efficacy. Methods: The clinical data of 27 patients treated in our hospital were selected. The patients were divided into treatment group (n = 15) and control group (n = 12). The control group was treated with Digoxin, ACEI and diuretic. The treatment group was given intravenous amiodarone and oral amiodarone on the basis of the control group, and the clinical curative effect of the two groups was observed. Results: In the treatment group, the improvement of cardiac function and the recovery effect were significantly higher than those of the control group (P <0.05). Conclusion: Amiodarone has a significant improvement in the treatment of heart failure and atrial fibrillation symptoms, which is worthy of clinical promotion.